Literature DB >> 15475610

Jak2 tyrosine kinase: a true jak of all trades?

Eric M Sandberg1, Tiffany A Wallace, Michael D Godeny, Danielle VonDerLinden, Peter P Sayeski.   

Abstract

Discovered roughly 10 yr ago, Jak2 tyrosine kinase has emerged as a critical molecule in mammalian development, physiology, and disease. Here, we review the early history of Jak2 and its role in health and disease. We will also review its critical role in mediating cytokine-dependent signal transduction. Additionally, more recent work demonstrating the importance of Jak2 in G protein-coupled receptor and tyrosine kinase growth factor receptor signal transduction will be discussed. The cellular and biochemical mechanisms by which Jak2 tyrosine kinase is activated and regulated within the cell also will be reviewed. Finally, structure-function and pharmacological-based studies that identified structural motifs and amino acids within Jak2 that are critical for its function will be examined. By reviewing the biology of Jak2 tyrosine kinase at the molecular, cellular, and physiological levels, we hope to advance the understanding of how a single gene can have such a profound impact on development, physiology, and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475610     DOI: 10.1385/cbb:41:2:207

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  18 in total

1.  The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

Authors:  David P Steensma; Gordon W Dewald; Terra L Lasho; Heather L Powell; Rebecca F McClure; Ross L Levine; D Gary Gilliland; Ayalew Tefferi
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

2.  c-Abl activates janus kinase 2 in normal hematopoietic cells.

Authors:  Wenjing Tao; Xiaohong Leng; Sandip N Chakraborty; Helen Ma; Ralph B Arlinghaus
Journal:  J Biol Chem       Date:  2014-06-12       Impact factor: 5.157

3.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

4.  The constitutive activation of Jak2-V617F is mediated by a π stacking mechanism involving phenylalanines 595 and 617.

Authors:  Kavitha Gnanasambandan; Andrew Magis; Peter P Sayeski
Journal:  Biochemistry       Date:  2010-10-29       Impact factor: 3.162

5.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

6.  Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.

Authors:  Jixin Zhong; Ping Yang; Kenjiro Muta; Robert Dong; Mario Marrero; Feili Gong; Cong-Yi Wang
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

7.  JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

Authors:  Amy V Jones; Andrew Chase; Richard T Silver; David Oscier; Katerina Zoi; Y Lynn Wang; Holger Cario; Heike L Pahl; Andrew Collins; Andreas Reiter; Francis Grand; Nicholas C P Cross
Journal:  Nat Genet       Date:  2009-03-15       Impact factor: 38.330

8.  Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.

Authors:  Britt N Fuglesteg; Naushaad Suleman; Crina Tiron; Tambuzai Kanhema; Lydia Lacerda; Thomas V Andreasen; Michael N Sack; Anne K Jonassen; Ole D Mjøs; Lionel H Opie; Sandrine Lecour
Journal:  Basic Res Cardiol       Date:  2008-05-23       Impact factor: 17.165

9.  Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation.

Authors:  Issam McDoom; Xianyue Ma; Annet Kirabo; Kuang-Yung Lee; David A Ostrov; Peter P Sayeski
Journal:  Biochemistry       Date:  2008-07-18       Impact factor: 3.162

10.  AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.

Authors:  Joana P Couto; Ana Almeida; Laura Daly; Manuel Sobrinho-Simões; Jacqueline F Bromberg; Paula Soares
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.